Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-670

First 670 Last

Share
Profile

Follow
Knowyourrisk

275 Posts.

58

17/11/18

10:51

Post #: 36541981
Share

Originally posted by Lalado ↑

Originally posted by Davisite
I haven't claimed that I am a big scientific person - no serious scientist was ever make such a claim. I do have a PhD and have worked in the biotech industry for the last 20 years. I do have some general experience in this area, but I haven't worked professionally in the HIV area for almost 30 years. I have enjoyed getting up to speed on HIV again as there has been a lot of progress made in the last few years.
seems that you are an expert in many fields, biotech specialist, psychology specialist, selective data analyst but definitely not a market analyst as the market seems to know more than you. IMO your behaviour reeks of a stock manipulator looking to spook market investors/traders to stimulate dumping of stock through fear so you can get back in or accumulate. No doubt you have some semblance of intelligence which make your discussions even more obvious that you have an ulterior motive . Stop treating everyone here as stupid as there are many valued contributors who seem to have a very good understanding of BIT. History indicates to me that psych 101 followers are usually a few electrons short of an atom themselves.
Lalado

Expand

I myself am getting annoyed with this. We all really need to ignore users who are causing our HC forum to be hijacked by total unnecessary debate
BIT by end of this month will put to rest the remaining leftover critics

BIT Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
23 Upvote

2 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Making money: How many microcaps should be in an investor's portfolio?

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Finance school vs reality: What they don't teach you about the stock market

There are more pages in this discussion • 369 more messages in this thread...

First 670 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change 0.000(0.00%)		Mkt cap ! $19.85M

Open	High	Low	Value	Volume
2.3¢	2.3¢	2.2¢	$20.69K	940.0K

Buyers (Bids)

No.	Vol.	Price($)
6	537628	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	141604	1

View Market Depth

No.	Vol.	Price($)
6	537628	0.021
8	454100	0.020
10	1899381	0.019
7	234054	0.018
4	408000	0.017

Price($)	Vol.	No.
0.022	141604	1
0.024	439576	4
0.025	600000	3
0.026	53847	1
0.027	162000	2

Last trade - 15.51pm 28/10/2024 (20 minute delay)

BIT (ASX) Chart

Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-670

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Making money: How many microcaps should be in an investor's portfolio?

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Finance school vs reality: What they don't teach you about the stock market

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-670

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Making money: How many microcaps should be in an investor's portfolio?

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Finance school vs reality: What they don't teach you about the stock market

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News